Monitoring the fitness of antiviral resistant influenza strains during an epidemic
Antivirals, such as oseltamivir,are an important pharmaceutical intervention for mitigating influenza epidemics and pandemics. In 2007, an oseltamivir-resistant seasonal A(H1N1) strain emerged and spread to global fixation within one year. This shows that antiviral-resistant (AVR) strains can be intrinsically more transmissible than its contemporaneous antiviral-sensitive (AVS) counterpart. Real-time surveillance of AVR fitness is therefore essential, especially in the context of influenza pandemics because many countries have stockpiled large amounts of antivirals for pandemic mitigation.
We developed a novel and simple method for estimating the fitness of AVR strains (defined as their transmissibility relative to co-circulating AVS strains) using data from that are routinely compiled by contemporary influenza AVR surveillance systems. This method requires only information on generation time but not other specific details regarding transmission dynamics. We want to test this method with simulations of a lot of disease transmission scenarios to show that this method yields unbiased and robust fitness estimates.